Quality of Life Among Polish Patients with Multiple Myeloma: A Cross-Sectional Study

13 November 2025 : Clinical Research

Magdalena Kurek

^{ABCDEF 1}, Tomasz Tatara

^{ADEF 1}, Jakub Świtalski

^{CDEF 2*}, Anna Augustynowicz

^{DE 3,4}, Barbara Łopyta^{DE 5}, Mariusz Gujski

^{DE 1}, Adam Fronczak^{ADEF 6}

DOI: 10.12659/MSM.948998

Med Sci Monit 2025; 31:e948998

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Patients by treatment method and sex.

Group	Sex	n	%	χ2	P value
Chemotherapy	Men	44	44.9%	1.02	0.312
Chemotherapy	Woman	54	55.1%	1.02	0.312
AutoHSCT	Men	39	44.8%	0.93	0.335
AutoHSCT	Woman	48	55.2%	0.93	0.335
Supportive therapy	Men	25	41.0%	1.98	0.159
Supportive therapy	Woman	36	59.0%	1.98	0.159
n – sample size; χ – chi square test value.

Back to the Article